Opko Health Net Income
| OPK Stock | USD 1.21 0.04 3.20% |
As of the 13th of February 2026, Opko Health holds the Variance of 3.6, coefficient of variation of (1,385), and Risk Adjusted Performance of (0.05). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Opko Health, as well as the relationship between them.
Opko Health Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 1.4638 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Loss | -47.9 M | -50.3 M | |
| Net Loss | -47.9 M | -50.3 M | |
| Net Loss | -295.6 M | -280.8 M | |
| Net Loss | (0.07) | (0.07) | |
| Net Income Per E B T | 4.62 | 4.85 |
Opko | Net Income | Build AI portfolio with Opko Stock |
Historical Net Income data for Opko Health serves as a key indicator of operational performance and financial stability. Tracking changes in this metric over time helps investors spot emerging trends before they become obvious, providing an edge in assessing whether Opko Health represents a compelling investment opportunity.
Latest Opko Health's Net Income Growth Pattern
Below is the plot of the Net Income of Opko Health over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Opko Health financial statement analysis. It represents the amount of money remaining after all of Opko Health operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Opko Health's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Opko Health's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (53.22 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Opko Net Income Regression Statistics
| Arithmetic Mean | (108,174,075) | |
| Geometric Mean | 54,291,627 | |
| Coefficient Of Variation | (107.54) | |
| Mean Deviation | 96,396,644 | |
| Median | (50,296,680) | |
| Standard Deviation | 116,332,041 | |
| Sample Variance | 13533.1T | |
| Range | 359M | |
| R-Value | (0.18) | |
| Mean Square Error | 13961.2T | |
| R-Squared | 0.03 | |
| Significance | 0.49 | |
| Slope | (4,175,180) | |
| Total Sum of Squares | 216530.3T |
Opko Net Income History
Other Fundumenentals of Opko Health
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Opko Health Net Income component correlations
Opko Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Opko Health is extremely important. It helps to project a fair market value of Opko Stock properly, considering its historical fundamentals such as Net Income. Since Opko Health's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Opko Health's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Opko Health's interrelated accounts and indicators.
Click cells to compare fundamentals
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Opko Health. Anticipated expansion of Opko directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Opko Health assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth (0.13) | Earnings Share (0.24) | Revenue Per Share | Return On Assets | Return On Equity |
The market value of Opko Health is measured differently than its book value, which is the value of Opko that is recorded on the company's balance sheet. Investors also form their own opinion of Opko Health's value that differs from its market value or its book value, called intrinsic value, which is Opko Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Opko Health's market value can be influenced by many factors that don't directly affect Opko Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Opko Health's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Opko Health should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Opko Health's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Opko Health 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Opko Health's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Opko Health.
| 11/15/2025 |
| 02/13/2026 |
If you would invest 0.00 in Opko Health on November 15, 2025 and sell it all today you would earn a total of 0.00 from holding Opko Health or generate 0.0% return on investment in Opko Health over 90 days. Opko Health is related to or competes with Sana Biotechnology, Claritev, Xencor, Oculis Holding, Personalis, Nektar Therapeutics, and Tandem Diabetes. OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States,... More
Opko Health Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Opko Health's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Opko Health upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.11) | |||
| Maximum Drawdown | 9.92 | |||
| Value At Risk | (2.99) | |||
| Potential Upside | 3.03 |
Opko Health Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Opko Health's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Opko Health's standard deviation. In reality, there are many statistical measures that can use Opko Health historical prices to predict the future Opko Health's volatility.| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (0.22) | |||
| Total Risk Alpha | (0.31) | |||
| Treynor Ratio | (0.15) |
Opko Health February 13, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.05) | |||
| Market Risk Adjusted Performance | (0.14) | |||
| Mean Deviation | 1.44 | |||
| Coefficient Of Variation | (1,385) | |||
| Standard Deviation | 1.9 | |||
| Variance | 3.6 | |||
| Information Ratio | (0.11) | |||
| Jensen Alpha | (0.22) | |||
| Total Risk Alpha | (0.31) | |||
| Treynor Ratio | (0.15) | |||
| Maximum Drawdown | 9.92 | |||
| Value At Risk | (2.99) | |||
| Potential Upside | 3.03 | |||
| Skewness | 0.9288 | |||
| Kurtosis | 1.96 |
Opko Health Backtested Returns
Opko Health maintains Sharpe Ratio (i.e., Efficiency) of -0.0319, which implies the firm had a -0.0319 % return per unit of risk over the last 3 months. Opko Health exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Opko Health's Coefficient Of Variation of (1,385), risk adjusted performance of (0.05), and Variance of 3.6 to confirm the risk estimate we provide. The company holds a Beta of 0.98, which implies possible diversification benefits within a given portfolio. Opko Health returns are very sensitive to returns on the market. As the market goes up or down, Opko Health is expected to follow. At this point, Opko Health has a negative expected return of -0.0621%. Please make sure to check Opko Health's information ratio, potential upside, as well as the relationship between the Potential Upside and rate of daily change , to decide if Opko Health performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.40 |
Average predictability
Opko Health has average predictability. Overlapping area represents the amount of predictability between Opko Health time series from 15th of November 2025 to 30th of December 2025 and 30th of December 2025 to 13th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Opko Health price movement. The serial correlation of 0.4 indicates that just about 40.0% of current Opko Health price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.4 | |
| Spearman Rank Test | -0.35 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Opko Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Opko Health reported net income of (53.22 Million). This is 115.6% lower than that of the Biotechnology sector and 130.75% lower than that of the Health Care industry. The net income for all United States stocks is 109.32% higher than that of the company.
Opko Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Opko Health's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Opko Health could also be used in its relative valuation, which is a method of valuing Opko Health by comparing valuation metrics of similar companies.Opko Health is currently under evaluation in net income category among its peers.
Opko Health Institutional Holders
Institutional Holdings refers to the ownership stake in Opko Health that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of Opko Health's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Opko Health's value.| Shares | Morgan Stanley - Brokerage Accounts | 2025-06-30 | 2.1 M | Awm Investment Company Inc | 2025-06-30 | 2 M | Dimensional Fund Advisors, Inc. | 2025-06-30 | 1.9 M | Graham Capital Management | 2025-06-30 | 1.9 M | Bank Of America Corp | 2025-06-30 | 1.9 M | Two Sigma Investments Llc | 2025-06-30 | 1.8 M | Whitefort Capital Management, Lp. | 2025-06-30 | 1.8 M | Y.d. More Investments Ltd | 2025-06-30 | 1.5 M | Jane Street Group Llc | 2025-06-30 | 1.4 M | Rubric Capital Management Lp | 2025-06-30 | 47.8 M | Vanguard Group Inc | 2025-06-30 | 38.2 M |
Opko Fundamentals
| Return On Equity | -0.13 | ||||
| Return On Asset | -0.0615 | ||||
| Profit Margin | (0.28) % | ||||
| Operating Margin | (0.35) % | ||||
| Current Valuation | 939.85 M | ||||
| Shares Outstanding | 767.7 M | ||||
| Shares Owned By Insiders | 48.70 % | ||||
| Shares Owned By Institutions | 26.12 % | ||||
| Number Of Shares Shorted | 30.88 M | ||||
| Price To Earning | 7.46 X | ||||
| Price To Book | 0.74 X | ||||
| Price To Sales | 1.55 X | ||||
| Revenue | 713.14 M | ||||
| Gross Profit | 121.55 M | ||||
| EBITDA | 135.28 M | ||||
| Net Income | (53.22 M) | ||||
| Cash And Equivalents | 210.46 M | ||||
| Cash Per Share | 0.27 X | ||||
| Total Debt | 504.44 M | ||||
| Debt To Equity | 0.16 % | ||||
| Current Ratio | 2.30 X | ||||
| Book Value Per Share | 1.70 X | ||||
| Cash Flow From Operations | (183.49 M) | ||||
| Short Ratio | 8.45 X | ||||
| Earnings Per Share | (0.24) X | ||||
| Price To Earnings To Growth | (2.87) X | ||||
| Target Price | 3.56 | ||||
| Number Of Employees | 3 K | ||||
| Beta | 1.49 | ||||
| Market Capitalization | 992.23 M | ||||
| Total Asset | 2.2 B | ||||
| Retained Earnings | (2.07 B) | ||||
| Working Capital | 468.99 M | ||||
| Current Asset | 454.06 M | ||||
| Current Liabilities | 251.9 M | ||||
| Net Asset | 2.2 B |
About Opko Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Opko Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Opko Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Opko Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out For more information on how to buy Opko Stock please use our How to buy in Opko Stock guide.You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Opko Health. Anticipated expansion of Opko directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Opko Health assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth (0.13) | Earnings Share (0.24) | Revenue Per Share | Return On Assets | Return On Equity |
The market value of Opko Health is measured differently than its book value, which is the value of Opko that is recorded on the company's balance sheet. Investors also form their own opinion of Opko Health's value that differs from its market value or its book value, called intrinsic value, which is Opko Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Opko Health's market value can be influenced by many factors that don't directly affect Opko Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Opko Health's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Opko Health should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Opko Health's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.